Global Neglected Tropical Disease Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Neglected Tropical Disease Market Analysis

  • Healthcare
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Frequently Asked Questions

The Neglected Tropical Disease Market will be projected to grow at a CAGR of 5.75% during forecast by 2029.
The Neglected Tropical Disease Market will be projected at USD 2.04 billion during forecast by 2029.
The major players operating in the Neglected Tropical Disease Market are GlaxoSmithKline plc., Bayer AG, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences, Inc., Astellas Pharma Inc., Sanofi, Eisai Co., Ltd., Merck KGaA, among others.
The major countries covered in the Neglected Tropical Disease Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.